Close Menu

NEW YORK (GenomeWeb News) – Dionex, a maker of liquid chromatography analysis systems, said today that it plans to buy ESA Biosciences' life sciences assets from ESA's parent company, Magellan Biosciences, including ESA's HPLC systems and clinical assays, as well as lab services.

The asset purchase agreement will give Sunnyvale, Calif.-based Dionex three lines of HPLC detectors. These products include the Corona Universal Charged Aerosol Detectors, which Dionex will sell with its own HPLC equipment or directly on third party systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.